Cystatin C: more evidence of its benefit
I am aware of the fact that I have done many blogs on cystatin C, perhaps too many. But, it seems to me that having as accurate a measure of estimated GFR is really important in terms of patient care, since so many issues depend on that, including the potential accuracy of medication-dosing based on renal function, as well as the treatment of the renal insufficiency itself. In that light, I herewith present the latest evaluation, this one finding that incorporating Cystatin C into the calculation of eGFR in older patients improved the prediction for all-cause mortality, the necessity for renal replacement therapy, as well as 6 other clinically important outcomes ( see ckd cystatin c better in older pts AIM2024 in dropbox, or doi:10.7326/M23-1138 ). Details: -- 82,154 people at least 65 years old who had outpatient creatinine and cystatin C measurements in this Swedish study, with information from 2010-2019 -- the SCREAM database (Stockholm CREAtinine Measurements) includes i